actilyse 50mg injection - Alteplase (50mg) medicine

Actilyse 50mg Injection (Alteplase): Complete Medicine Guide

No reviews yet
🏭 Boehringer Ingelheim 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 26, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for approved indications.
Reviewed by
SaathiMed Expert Panel | Sep 26, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Sudden severe headache, confusion, or loss of consciousness
  • Vomiting blood or passing black tarry stools
  • Severe abdominal or back pain
  • Difficulty breathing or swelling of the face, lips, or throat
  • Sudden weakness or numbness on one side of the body
  • Bleeding that does not stop after applying pressure
  • Chest pain or irregular heartbeat

If experiencing severe symptoms, call emergency services immediately.

What is actilyse 50mg injection used for?

This medicine is a clot-dissolving injection containing alteplase 50 mg. It is used in hospitals for emergency conditions such as acute ischemic stroke, heart attack, and massive pulmonary embolism. It works by converting plasminogen to plasmin, which breaks down blood clots. It is given only by intravenous infusion under strict medical supervision because of a high risk of serious bleeding.

  • Generic Name: Alteplase
  • Manufacturer: Boehringer Ingelheim
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 actilyse 50mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा एक शक्तिशाली क्लॉट-भंग करने वाली इंजेक्शन है जिसमें एल्टेप्लेज 50 मिलीग्राम होता है। इसका उपयोग अस्पताल में आपातकालीन स्थितियों जैसे दिमाग की नस में खून का थक्का जमने (इस्केमिक स्ट्रोक), दिल का दौरा, और फेफड़ों की धमनी में खतरनाक थक्के के इलाज के लिए किया जाता है। यह दवा खून के थक्के को घोलकर रक्त प्रवाह बहाल करती है। इसे केवल डॉक्टर की देखरेख में नस के माध्यम से दिया जाता है। घर पर इसका उपयोग बिल्कुल न करें।

साइड इफेक्ट्स: इस दवा का सबसे गंभीर दुष्प्रभाव खून बहना है, जो इंजेक्शन लगाने की जगह, पेट, आंत, मूत्र मार्ग या दिमाग में हो सकता है। हल्के दुष्प्रभावों में मसूड़ों से खून आना, नाक से खून आना, जी मिचलाना, उल्टी, कम रक्तचाप, बुखार या ठंड लगना शामिल हैं। दिमाग में खून बहना एक गंभीर लेकिन दुर्लभ दुष्प्रभाव है। अगर सांस लेने में तकलीफ, चेहरे या गले में सूजन, तेज सिरदर्द, भ्रम, या बोलने में कठिनाई हो तो तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल अस्पताल में योग्य डॉक्टर द्वारा दी जानी चाहिए, घर पर कभी नहीं। इलाज से पहले अपने डॉक्टर को सभी दवाओं के बारे में बताएं, खासकर खून पतला करने वाली दवाएं, दर्द निवारक दवाएं, और हर्बल सप्लीमेंट। हाल की सर्जरी, चोट, रक्तस्राव की समस्या, स्ट्रोक, ब्रेन ट्यूमर, प्रेग्नेंसी या अनियंत्रित उच्च रक्तचाप के बारे में जरूर बताएं। इलाज के बाद चोट लगने वाली गतिविधियों से बचें और असामान्य खून बहना, चोट के निशान, तेज सिरदर्द, कमजोरी या बोलने में कठिनाई होने पर तुरंत डॉक्टर को सूचित करें। डॉक्टर की अनुमति के बिना गाड़ी न चलाएं।

💡 Did You Know? The first generic medicine was introduced in India in 1970 after the Patents Act was amended.

💊 actilyse 50mg injection Uses & Benefits

[{"condition":"Acute ischemic stroke","description":"Used within a carefully selected time window to dissolve the clot and restore blood flow to the brain, reducing disability when given to eligible patients.","evidence":"Well-established"},{"condition":"Acute myocardial infarction (heart attack)","description":"Used to dissolve coronary artery clots and restore blood flow to the heart muscle when primary percutaneous coronary intervention is not immediately available.","evidence":"Well-established"},{"condition":"Massive pulmonary embolism","description":"Used in life-threatening pulmonary embolism with haemodynamic instability to dissolve clots in the pulmonary arteries.","evidence":"Well-established"},{"condition":"Occluded central venous catheters","description":"Instilled locally into a blocked catheter to restore patency when other measures fail.","evidence":"Well-established"},{"condition":"Acute peripheral arterial occlusion","description":"Used in selected patients with sudden limb-threatening arterial blockage to restore blood flow.","evidence":"Established in selected patients"}]

Off-label uses: [{"condition":"Intraventricular haemorrhage with intraventricular clot","description":"Sometimes used off-label in selected neurosurgical patients to help dissolve intraventricular blood clots.","evidence":"Limited"},{"condition":"Retinal artery occlusion","description":"Occasionally used off-label in specialised centres for sudden loss of vision due to retinal artery clot.","evidence":"Limited"},{"condition":"Frostbite","description":"Rarely used off-label in severe frostbite to improve blood flow in affected tissues.","evidence":"Limited"}]

Primary treatment for: Acute ischemic stroke, acute myocardial infarction, and massive pulmonary embolism

Also treats: Occluded central venous catheters, Acute peripheral arterial occlusion

📋 Drug Information

Generic Name(s)Alteplase
Brand NameActilyse
ManufacturerBoehringer Ingelheim
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassCARDIAC
Action ClassPlasminogen Activators- Thrombolytics
Route of AdministrationIntravenous (IV) infusion, and in some cases intra-arterial infusion for local clot dissolution. It is also used locally for occluded catheters
StorageStore the lyophilised powder at 2°C to 25°C. Protect from light. After reconstitution, use immediately or store as directed by the manufacturer and institutional policy. Do not freeze.
Shelf LifeRefer to the product label for the exact shelf life. Typically 24 to 36 months from the date of manufacture when stored as directed.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
This medicine must be given only in a hospital setting with continuous monitoring for bleeding.
2
Assess the risk of bleeding carefully before starting treatment, especially in elderly patients.
3
Avoid invasive procedures such as arterial punctures during and shortly after the infusion.
4
Keep blood products and emergency equipment ready before administering this medicine.
5
Monitor neurological status closely in stroke patients and cardiac rhythm in heart attack patients.
6
Document the exact time of symptom onset and infusion start, as timing is critical for outcomes.
7
Use the weight-based dose according to the specific protocol for each indication.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Sudden weakness or numbness on one side of the body
This medicine may be used in acute ischemic stroke after evaluation.
Likely Use
✅
Severe chest pain with sweating
This medicine may be used in acute myocardial infarction when angioplasty is not immediately available.
Likely Use
✅
Sudden shortness of breath with low blood pressure
This medicine may be used in massive pulmonary embolism.
Likely Use
❌
Mild headache
This medicine is not used for mild headaches.
Not Primary
❌
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is given directly into the bloodstream by intravenous infusion, so absorption from the gastrointestinal tract does not apply. The full dose enters the circulation immediately after infusion.
DistributionThis medicine distributes primarily within the vascular space and binds to fibrin in clots. It is cleared rapidly from the blood, mainly by the liver.
Protein BindingNot established from the available information.
MetabolismThis medicine is metabolised primarily in the liver, where it is taken up by hepatocytes and degraded. It is not metabolised by the cytochrome P450 system.
Half-LifeThe initial half-life is approximately 4 to 5 minutes, with a slower terminal phase due to continued release from clots.
ExcretionDegradation products are cleared from the circulation, and the medicine is eliminated mainly through hepatic metabolism. Renal excretion is not a major route.
BioavailabilityBioavailability is 100% because this medicine is administered directly into the bloodstream by intravenous infusion.
Onset of ActionClot dissolution begins during the infusion, and clinical effects such as restored blood flow can be seen within minutes to hours depending on the site and size of the clot.
Peak Plasma TimePlasma levels peak during or immediately after the intravenous infusion.
Duration of ActionThe clot-dissolving effect lasts for several hours after the infusion, but the risk of bleeding can persist longer because clotting factors may remain depleted.

How It Works

This medicine is a recombinant form of human tissue plasminogen activator. It binds to fibrin in a blood clot and converts clot-bound plasminogen into plasmin. Plasmin then breaks down the fibrin network that holds the clot together, leading to clot dissolution and restoration of blood flow. Because it preferentially activates plasminogen bound to fibrin, its action is relatively clot-selective, but it can still cause systemic bleeding by generating plasmin in the circulation.

Mechanism Steps

1
Binding to fibrin in the clot: This medicine binds selectively to fibrin, the protein mesh that forms the framework of a blood clot.
2
Activation of plasminogen: Once bound to fibrin, this medicine converts plasminogen that is also bound to fibrin into active plasmin.
3
Fibrin degradation: Plasmin breaks down fibrin into soluble fragments, weakening and dissolving the clot.
4
Restoration of blood flow: As the clot dissolves, blood flow is restored to the affected organ, reducing tissue damage.
5
Systemic bleeding risk: Some plasmin is generated in the circulation, which can degrade clotting factors and increase the risk of bleeding elsewhere in the body.

💡 How to Take actilyse 50mg injection

Strength: Lyophilised powder for solution for injection or infusion, 50 mg per vial.

1This medicine is given only by a qualified healthcare professional in a hospital setting.
2The powder is reconstituted with the sterile water provided and then diluted in an appropriate solution.
3It is administered as an intravenous bolus followed by an infusion, or as a local instillation for catheters.
4Vital signs and bleeding status are monitored continuously during and after the infusion.
5Do not attempt to administer this medicine at home or without medical supervision.

Dosage Information

Adult DosageThe dose of this medicine depends on the condition being treated and must be individualised by a qualified clinician. For acute ischemic stroke, a common regimen is a total dose based on body weight, given as a bolus followed by an infusion over 60 minutes. For acute myocardial infarction, a weight-based accelerated infusion regimen is often used. For massive pulmonary embolism, a weight-based dose is given over 2 hours. For occluded catheters, a small local dose is instilled. Dose must be individualised by a qualified clinician based on indication, age, weight, renal and hepatic function, and bleeding risk.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients have a higher risk of bleeding, especially intracranial haemorrhage. The dose is generally the same as for younger adults, but the decision to use this medicine must carefully weigh the benefits against the risks. Close monitoring is essential.
Renal ImpairmentNo specific dose adjustment is established for renal impairment, but use with caution in patients with severe kidney disease because of an increased risk of bleeding.
Hepatic ImpairmentNo specific dose adjustment is established for hepatic impairment, but use with caution in patients with severe liver disease because of an increased risk of bleeding.
Maximum Daily DoseThe maximum dose depends on the indication and is determined by the treating clinician. Do not exceed the prescribed dose.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

No specific food interactions
No dietary restrictions required
This medicine is given intravenously and does not interact with food.

⏰ What to Do If You Miss a Dose

📌 This medicine is given as a single course in hospital
→ Missed doses are not applicable.
💡 The medical team manages the infusion schedule.
📌 If an infusion is interrupted
→ Inform the medical team immediately.
💡 Do not attempt to restart or adjust the infusion yourself.

⚠️ Side Effects of actilyse 50mg injection

✅ Common Side Effects

Bleeding from puncture sites or gums (Common)
Apply pressure to the site and inform the medical team. Most minor bleeding stops with local measures.
Nausea (Common)
Inform the nursing staff. Anti-nausea medicines may be given if needed.
Low blood pressure (Common)
The medical team will monitor blood pressure and may adjust the infusion rate or give fluids.
Fever or chills (Uncommon)
Inform the medical team. This usually settles without specific treatment.

🚨 Serious Side Effects

Intracranial haemorrhage (bleeding in the brain) (Uncommon but serious)
Seek immediate medical attention if you develop sudden severe headache, confusion, weakness, difficulty speaking, or loss of consciousness.
Gastrointestinal haemorrhage (Uncommon)
Report vomiting blood, black tarry stools, or severe abdominal pain immediately.
Retroperitoneal bleeding (Rare)
Report severe back or flank pain, weakness, or a drop in blood pressure.
Anaphylaxis (Rare)
Seek emergency help for swelling of the face, lips, or throat, difficulty breathing, or a widespread rash.
Reperfusion arrhythmias (Uncommon)
The medical team will monitor the heart rhythm continuously and treat arrhythmias if they occur.

⚠️ Rare Side Effects

Cholesterol embolisation
Report blue or painful toes, skin mottling, or worsening kidney function.
Cardiac rupture after heart attack
Seek emergency care for sudden severe chest pain, collapse, or difficulty breathing.
Pulmonary haemorrhage
Report coughing up blood or sudden shortness of breath.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Warfarin Major
Heparin Major
Aspirin Major
Clopidogrel Major
Rivaroxaban Major
Apixaban Major
Dabigatran Major
Ibuprofen Major
ACE inhibitors Moderate
Nitroglycerin Moderate

🚨 Major Interactions

  • Warfarin and other vitamin K antagonists
  • Heparin, low molecular weight heparin, and fondaparinux
  • Direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban)
  • Antiplatelet agents (aspirin, clopidogrel, ticagrelor, prasugrel)
  • Non-steroidal anti-inflammatory drugs (NSAIDs)

⚡ Moderate Interactions

  • Angiotensin-converting enzyme inhibitors
  • Nitroglycerin
  • Cephalosporins with methylthiotetrazole side chain

🍷 Alcohol Interaction

Alcohol can increase the risk of bleeding and may worsen liver function. Avoid alcohol during treatment and for as long as your doctor advises.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Active internal bleeding","History of intracranial haemorrhage","Known bleeding diathesis","Recent major surgery or trauma","Severe uncontrolled hypertension","Recent stroke or brain surgery","Intracranial neoplasm, arteriovenous malformation, or aneurysm","Suspected aortic dissection","Acute pericarditis","Severe liver disease","Pregnancy or recent childbirth, except in life-threatening situations"]

⚠️ Warnings & Precautions

["This medicine must be given only in a hospital setting with access to emergency care and blood products.","The risk of bleeding is high, and patients must be monitored closely.","Avoid invasive procedures such as arterial punctures during treatment whenever possible.","Use with caution in elderly patients, who have a higher risk of bleeding.","Use with caution in patients with severe kidney or liver disease.","Do not use in patients with known hypersensitivity to alteplase or any component of the formulation.","Reconstituted solution should be used promptly and handled according to institutional protocols."]

🤱 Lactation Safety

It is not known whether this medicine passes into breast milk. Because it is given in emergency situations, breastfeeding should be discussed with the treating doctor. In many cases, breastfeeding may need to be interrupted temporarily.

💊 Overdose Management

Overdose with this medicine can cause severe bleeding. There is no specific antidote, but treatment includes stopping the infusion immediately, applying local pressure to bleeding sites, and giving blood products such as fresh frozen plasma, cryoprecipitate, or platelets as needed. Antifibrinolytic agents such as tranexamic acid may be considered in severe cases. Supportive care and close monitoring are essential.

⏰ Missed Dose

This medicine is given as a single course or short infusion in a hospital setting, so missed doses are not applicable. If a dose is interrupted, the medical team will decide whether to continue or restart based on the clinical situation.

Additional Safety Advice

General Safety

This medicine must be given only by a qualified clinician in a hospital or emergency setting, never at home. Before treatment, tell the medical team about all medicines you take, especially blood thinners such as warfarin, heparin, low molecular weight heparin, direct oral anticoagulants, antiplatelet drugs, and non-steroidal anti-inflammatory drugs. Inform them about any recent surgery, trauma, bleeding problems, stroke, brain tumour, pregnancy, or uncontrolled high blood pressure. After treatment, avoid activities that could cause injury or bleeding, and report any unusual bruising, bleeding gums, nosebleeds, blood in urine or stool, severe headache, confusion, weakness, or difficulty speaking immediately. Do not drive or operate machinery until your doctor confirms it is safe. Keep all follow-up appointments for monitoring and imaging. Do not take any new medicine, including over-the-counter painkillers, without asking your doctor first.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients have a higher risk of bleeding, especially intracranial haemorrhage, after receiving this medicine. The decision to use it must carefully weigh the benefits against the risks. Close monitoring and dose adjustment as per protocol are essential.

🤰 Pregnancy Planning (TTC)

This medicine is used only in life-threatening emergencies during pregnancy. If you are planning pregnancy or are pregnant, inform your doctor immediately. The risks and benefits will be discussed by the specialist team.

🏥 Post-Surgery Considerations

This medicine is generally avoided after recent surgery because of the high risk of bleeding. If surgery is planned, inform your surgeon if you have received this medicine recently. The timing of surgery after treatment will be decided by your doctor.

🦷 Dental Procedures

Inform your dentist if you have recently received this medicine. Dental procedures that cause bleeding may need to be postponed until your doctor confirms it is safe. Good oral hygiene is important to prevent gum bleeding.

💚 Lifestyle Tips for Better Results

🏃
Follow a heart-healthy diet low in saturated fats and salt.
🥗
Stay physically active as advised by your doctor.
😴
Avoid smoking and limit alcohol intake.
💧
Take all prescribed medicines for blood pressure, diabetes, and cholesterol regularly.
🧘
Attend all follow-up appointments and rehabilitation sessions.
🌞
Learn the warning signs of stroke and heart attack and act fast.

🏋️ Exercise Considerations

Avoid strenuous exercise and activities that could cause injury or bleeding for at least a few days after treatment, or as advised by your doctor. Gradually resume activity under medical guidance.

🥗 Diet Recommendations

Eat plenty of fruits and vegetables.
Choose whole grains and lean proteins.
Limit salt, sugar, and processed foods.
Stay well hydrated unless your doctor restricts fluids.
Avoid alcohol during and shortly after treatment.

💼 Impact on Daily Work & Life

After receiving this medicine, you will need time to recover in hospital and at home. Do not drive or operate machinery until your doctor confirms it is safe. Depending on your condition, you may need rehabilitation before returning to work. Discuss your work schedule with your doctor.

🛑 When to Stop This Medicine

This medicine is given as a short course in hospital, so you do not decide when to stop it. The medical team will stop the infusion based on your clinical response and any complications. After discharge, follow your doctor's advice on other medicines and lifestyle changes.

📅 Long-Term Use Effects

This medicine is usually given as a short course in an emergency setting, so long-term effects are not common. However, patients who survive a stroke or heart attack may need long-term rehabilitation and preventive medicines. The risk of bleeding can persist for some time after treatment, so follow-up monitoring is important. Regular check-ups with your doctor are recommended to manage the underlying condition and prevent future clots.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Mechanical thrombectomy

A procedure to remove the clot physically in selected stroke patients.

Evidence: Well-established
Primary percutaneous coronary intervention

Angioplasty and stenting to open blocked coronary arteries in heart attack.

Evidence: Well-established
Anticoagulation

Use of blood thinners to prevent further clots in some conditions.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

There are no specific vaccine interactions reported with this medicine. However, if you have recently received a live vaccine or are due for one, inform your doctor. Vaccination should be planned according to your overall medical condition.

📦 Storage Guide

✅ DO

Store the lyophilised powder at 2°C to 25°C.

❌ DON'T

Do not freeze the product.

✅ DO

Protect the vial from light.

❌ DON'T

Do not use if the solution is discoloured or contains particles.

✅ DO

Use the reconstituted solution promptly as directed.

❌ DON'T

Do not store reconstituted solution for long periods unless specified.

✈️ Traveling with This Medicine

This medicine is given only in a hospital setting, so travel advice is mainly for patients who have received it. Carry a copy of your discharge summary and prescription, especially if you are travelling soon after treatment. Avoid long journeys immediately after treatment because of the risk of bleeding and the need for follow-up. If you must travel, inform your doctor and carry enough of any other prescribed medicines in their original packaging. Keep a list of your medicines and allergies with you at all times. Follow up with a doctor at your destination if you experience any bleeding or unusual symptoms.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 62-year-old man brought to the emergency department with sudden weakness on the right side and difficulty speaking.
He was evaluated quickly, and imaging confirmed an acute ischemic stroke. He received this medicine as an intravenous infusion within the treatment window. His symptoms improved over the next few hours, and he was monitored closely for bleeding. He was discharged with rehabilitation and made a good recovery.
💡 Lesson: Time is critical in stroke treatment. This medicine can reduce disability when given promptly to eligible patients.
👤 A 55-year-old woman with a history of heart disease developed severe chest pain and was diagnosed with a heart attack.
Because immediate angioplasty was not available, she was given this medicine to dissolve the clot in her coronary artery. Her chest pain improved, and follow-up tests showed restored blood flow. She was monitored for bleeding and later underwent further cardiac evaluation.
💡 Lesson: This medicine can be life-saving in heart attack when primary angioplasty is not immediately available, but close monitoring is essential.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts dissolving the clot during the infusion, and clinical effects can be seen within minutes to hours depending on the site and size of the clot.

Q: Can I take this medicine at home?

A: No. This medicine is given only in a hospital setting by a qualified clinician because of the high risk of serious bleeding.

Q: What are the serious side effects?

A: The most serious side effect is severe bleeding, including bleeding in the brain, gastrointestinal bleeding, and allergic reactions. Seek immediate medical help if you notice any signs of bleeding.

Q: Who should not receive this medicine?

A: It should not be given to patients with active internal bleeding, recent major surgery, severe uncontrolled high blood pressure, a history of bleeding in the brain, certain brain tumours, or a recent stroke.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can this medicine be given at home?
  • What are the chances of bleeding with this medicine?
  • How long does the effect of this medicine last?
  • Can this medicine be used in pregnancy?
  • What should I do if I miss a dose?
  • Does this medicine interact with blood thinners?

🛑 Myths vs. Facts

  • Myth: This medicine can be taken as a tablet at home.
    Fact: This medicine is an injection given only in a hospital setting by a qualified clinician.
  • Myth: This medicine is safe for everyone with a blood clot.
    Fact: It is contraindicated in many conditions, especially those with a high risk of bleeding.
  • Myth: This medicine has no serious side effects.
    Fact: The most serious side effect is severe bleeding, including bleeding in the brain.

🔄 Alternative Options

Brand Alternatives

📊 Comparison with Similar Medicines

[{"medicine":"This medicine (alteplase)","class":"Recombinant tissue plasminogen activator","route":"Intravenous","main_use":"Stroke, heart attack, pulmonary embolism","half_life":"4 to 5 minutes"},{"medicine":"Tenecteplase","class":"Recombinant tissue plasminogen activator","route":"Intravenous","main_use":"Heart attack, selected stroke cases","half_life":"Longer than alteplase"},{"medicine":"Reteplase","class":"Recombinant plasminogen activator","route":"Intravenous","main_use":"Heart attack","half_life":"Longer than alteplase"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory